Notably, 56% of examined EYFP-negative tumors halved into HCC and benign lesions, including dysplasia (7%), RNs (17%) and HCA (23%) (Figure 5D), suggesting that these EYFP-negative tumors may derive from hepatocytes and/or Sox9-negative cells. This evidence concerns the gene SOX9 and hepatocellular carcinoma.